Cross-Site Scripting (XSS) in GuppY
This vulnerability was discovered by our security researchers before 2019.
| Advisory ID: | HTB23176 |
| Product: | GuppY |
| Vendor: | GuppY |
| Vulnerable Versions: | 4.6.26 and probably prior |
| Tested Version: | 4.6.26 |
| Advisory Publication: | October 2, 2013 [without technical details] |
| Vendor Notification: | October 2, 2013 |
| Vendor Fix: | October 12, 2013 |
| Public Disclosure: | October 23, 2013 |
| Latest Update: | October 14, 2013 |
| Vulnerability Type: | Cross-Site Scripting [CWE-79] |
| CVE Reference: | CVE-2013-5983 |
| Risk Level: | Medium |
| CVSSv2 Base Score: | 4.3 (AV:N/AC:M/Au:N/C:N/I:P/A:N) |
| Solution Status: | Fixed by Vendor |
| Discovered and Provided: | High-Tech Bridge Security Research Lab |
| Advisory Details: | |
High-Tech Bridge Security Research Lab discovered two XSS vulnerabilities in GuppY, which can be exploited to perform Cross-Site Scripting attacks against users of vulnerable application. | |
| Solution: | |
| Update to GuppY 4.6.28 More Information: http://www.freeguppy.org/thread.php?lng=en&pg=244900&cat=200 | |
| | |
References: | |
| [1] High-Tech Bridge Advisory HTB23176 - https://www.immuniweb.com/advisory/HTB23176 - Cross-Site Scripting (XSS) in GuppY. [2] GuppY - http://www.freeguppy.org - GuppY the easy web portal that requires no database. [3] Common Vulnerabilities and Exposures (CVE) - http://cve.mitre.org/ - international in scope and free for public use, CVE® is a dictionary of publicly known information security vulnerabilities and exposures. [4] Common Weakness Enumeration (CWE) - http://cwe.mitre.org - targeted to developers and security practitioners, CWE is a formal list of software weakness types. [5] ImmuniWeb® - Leveraging the power of machine-learning and genius of human brain to deliver the most advanced web application security and penetration testing. [6] ImmuniWeb® SSLScan - Test your servers for security and compliance with PCI DSS, HIPAA and NIST. | |
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.